Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2005-11-1
pubmed:abstractText
The stomach is the most common site of origin for extranodal lymphomas. While resection has played a major part in the management of such patients in the past, in recent years there has been a change towards organ-conserving therapies. However, the risk of perforation and bleeding in patients undergoing organ-conserving therapy has been used as an argument against primary application of chemotherapy. In this article, we present our experience with the prophylactic use of oral pantoprazole.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo..., http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal..., http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Proton Pumps, http://linkedlifedata.com/resource/pubmed/chemical/Sulfoxides, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine, http://linkedlifedata.com/resource/pubmed/chemical/pantoprazole, http://linkedlifedata.com/resource/pubmed/chemical/rituximab
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0036-5521
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1222-5
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16265779-2-Pyridinylmethylsulfinylbenzimidazoles, pubmed-meshheading:16265779-Administration, Oral, pubmed-meshheading:16265779-Adult, pubmed-meshheading:16265779-Aged, pubmed-meshheading:16265779-Aged, 80 and over, pubmed-meshheading:16265779-Anti-Ulcer Agents, pubmed-meshheading:16265779-Antibodies, Monoclonal, pubmed-meshheading:16265779-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:16265779-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16265779-Benzimidazoles, pubmed-meshheading:16265779-Cyclophosphamide, pubmed-meshheading:16265779-Doxorubicin, pubmed-meshheading:16265779-Follow-Up Studies, pubmed-meshheading:16265779-Humans, pubmed-meshheading:16265779-Lymphoma, B-Cell, pubmed-meshheading:16265779-Lymphoma, B-Cell, Marginal Zone, pubmed-meshheading:16265779-Middle Aged, pubmed-meshheading:16265779-Mitoxantrone, pubmed-meshheading:16265779-Neoplasm Staging, pubmed-meshheading:16265779-Omeprazole, pubmed-meshheading:16265779-Patient Compliance, pubmed-meshheading:16265779-Prednisone, pubmed-meshheading:16265779-Proton Pumps, pubmed-meshheading:16265779-Stomach Neoplasms, pubmed-meshheading:16265779-Sulfoxides, pubmed-meshheading:16265779-Treatment Outcome, pubmed-meshheading:16265779-Vincristine
pubmed:year
2005
pubmed:articleTitle
Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
pubmed:affiliation
Department of Medicine I, Medical University Vienna, Austria.
pubmed:publicationType
Journal Article